{
  "meta": {
    "title": "Mood_Disorders",
    "url": "https://brainandscalpel.vercel.app/mood-disorders-650c7e8e.html",
    "scrapedAt": "2025-11-30T11:20:19.544Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Tremors</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Tardive dyskinesis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes insipidus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient with bipolar disorder has been on lithium for the last 1 year. Which of the following side effects is least likely to occur?</span></p>",
      "unique_key": "DT1154777",
      "question_audio": null,
      "question_video": null,
      "map_id": 1154777,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Tardive dyskinesia</strong> is primarily linked to long-term use of <strong>dopamine antagonists</strong> (e.g., typical antipsychotics), not <strong>lithium</strong>, making this the least likely side effect.</li>\n<li><strong>Lithium</strong> is associated with:\n<ul>\n<li><strong>Hypothyroidism</strong> &ndash; via inhibition of thyroid hormone synthesis and release.</li>\n<li><strong>Tremors</strong> &ndash; fine, dose-dependent, often managed with beta-blockers.</li>\n<li><strong>Nephrogenic diabetes insipidus</strong> &ndash; due to reduced renal sensitivity to ADH.<br /> (Option C ruled out)</li>\n</ul>\n</li>\n<li><strong>Pharmacokinetics &amp; Therapeutic Window</strong>:\n<ul>\n<li><strong>Half-life (t&frac12;):</strong> 20&ndash;24 hours (longer in elderly/renal impairment)</li>\n<li><strong>Therapeutic range:</strong>0.6&ndash;1.2 mEq/L</li>\n<li><strong>Maintenance level:</strong>0.6&ndash;0.8 mEq/L</li>\n<li><strong>Toxic level:</strong> &gt;1.5 mEq/L; severe toxicity &gt;2.0 mEq/L</li>\n</ul>\n</li>\n<li><strong>Other Side Effects</strong>:\n<ul>\n<li><strong>Weight gain</strong>, <strong>acne</strong>, <strong>leukocytosis</strong></li>\n<li><strong>Cognitive dulling</strong>, <strong>ECG changes (e.g., T wave flattening)</strong></li>\n<li><strong>GI symptoms</strong>: nausea, vomiting, diarrhea</li>\n<li><strong>Hyperparathyroidism</strong>, <strong>renal tubular acidosis</strong></li>\n<li><strong>Teratogenic</strong>: Ebstein&rsquo;s anomaly in neonates</li>\n</ul>\n</li>\n<li><strong>Indications for Hemodialysis</strong> in Lithium Toxicity:\n<ul>\n<li><strong>Serum lithium &gt;4.0 mEq/L</strong>, regardless of symptoms</li>\n<li><strong>Levels &gt;2.5 mEq/L</strong> with <strong>neurological symptoms</strong> or <strong>renal impairment</strong></li>\n<li><strong>Severe toxicity</strong>: coma, seizures, or rising levels despite hydration</li>\n<li><strong>Inability to clear lithium due to renal dysfunction</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Tardive dyskinesia is not linked to lithium use</strong>.</li>\n<li><strong>Hemodialysis is essential in severe lithium toxicity</strong>, especially with renal failure or neuro signs.</li>\n<li>Routine monitoring of <strong>serum lithium, renal, thyroid, and electrolyte status</strong> is crucial.</li>\n</ul>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluoxetine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old female presents to OPD with complaints of persistent sadness, sleeping problems, loss of interest in activities and poor appetite for the past few months. As per her condition, she is diagnosed with major depressive disorder. Which drug is the most appropriate for initial treatment?</span></p>",
      "unique_key": "DT1221678",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Fluoxetine</strong> is a <strong>selective serotonin reuptake inhibitor (SSRI)</strong> and is the <strong>first-line treatment</strong> for <strong>major depressive disorder (MDD)</strong> due to its efficacy, tolerability, and safety profile.</li>\n<li>SSRIs are especially preferred in <strong>initial treatment</strong> because they are <strong>less sedating</strong>, have <strong>minimal anticholinergic effects</strong>, and are <strong>relatively safe in overdose</strong>.</li>\n<li><strong>Lithium</strong> is used as an <strong>augmenting agent</strong> in treatment-resistant depression and as a mood stabiliser in <strong>bipolar disorder</strong>. <strong>(Option A ruled out)</strong></li>\n<li><strong>Buspirone</strong> is an <strong>anxiolytic</strong>, used for <strong>generalised anxiety disorder</strong>, not for depression. <strong>(Option B ruled out)</strong></li>\n<li><strong>Haloperidol</strong> is an <strong>antipsychotic</strong>, not indicated for primary depression. <strong>(Option C ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Fluoxetine</strong> is a first-line SSRI for <strong>major depressive disorder</strong>.</li>\n<li><strong>Lithium, Buspirone, and Haloperidol</strong> are not appropriate for initial monotherapy in MDD.</li>\n<li>SSRIs are preferred due to a favourable side effect profile and safety.</li>\n</ul>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Trazadone</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">MAO inhibitors</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Amitryptyline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person developed a sudden hypertensive episode after taking wine. Family members informed that he was already on psychiatric medication. Which of the following drug must the person be taking?</span></p>",
      "unique_key": "DT1221679",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221679,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Monoamine oxidase inhibitors (MAOIs)</strong> block the breakdown of <strong>tyramine</strong>, a compound found in aged foods like <strong>cheese and wine</strong>. When a person on MAOIs consumes tyramine-rich food or drink, it can lead to <strong>a hypertensive crisis</strong>&mdash;also called the <strong>&ldquo;cheese reaction&rdquo;</strong>&mdash;due to excessive <strong>norepinephrine release</strong>. (Option C ruled out)</li>\n<li><strong>SSRIs (A)</strong> and <strong>Trazodone (B)</strong> do not interact with tyramine in this way.</li>\n<li><strong>Amitriptyline (D)</strong> is a tricyclic antidepressant that can cause anticholinergic side effects but is <strong>not associated with tyramine-induced hypertensive crisis</strong>.</li>\n</ul>\n<p><strong>Other clinical uses of MAOIs:</strong></p>\n<ul>\n<li><strong>Atypical depression</strong> (with hypersomnia, increased appetite)</li>\n<li><strong>Treatment-resistant depression</strong></li>\n<li><strong>Panic disorder</strong></li>\n<li><strong>Social anxiety disorder</strong></li>\n<li><strong>Parkinson&rsquo;s disease</strong> (with selective MAO-B inhibitors like selegiline and rasagiline)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>MAOIs can cause hypertensive crisis</strong> when combined with <strong>tyramine-rich foods</strong>.</li>\n<li>Used in <strong>atypical or treatment-resistant depression</strong>, and certain <strong>anxiety and neurodegenerative disorders</strong>.</li>\n<li>Requires strict <strong>dietary restrictions</strong> and <strong>drug interaction awareness</strong>.</li>\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum Blues</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum Depression</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum Psychosis</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female is presented to the OPD with complaints of agitation, muttering to herself and sleep disturbances. She claims that her husband has stolen the baby from her womb. She delivered a healthy child three weeks back, however, has not taken care of the baby. What is the most probable diagnosis?</span></p>",
      "unique_key": "DT1221680",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221680,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Postpartum psychosis typically presents within the first few weeks after delivery. It often includes <strong>delusions (including bizarre or nihilistic types), hallucinations, disorganised behaviour, severe mood disturbance</strong>, and lack of insight. In this case, the <strong>delusion that the baby has been stolen from her womb</strong> is characteristic. Immediate psychiatric evaluation and often <strong>hospitalisation</strong> are required to protect both mother and child.</p>\n<ul>\n<li>Onset usually within <strong>2&ndash;4 weeks postpartum</strong></li>\n<li>Symptoms: <strong>Delusions, hallucinations, disorganised thoughts, sleep disturbance, and rejection of the infant</strong></li>\n<li>May be related to bipolar disorder or schizoaffective disorder</li>\n<li>Management: <strong>Urgent psychiatric referral</strong>, possible <strong>antipsychotics or mood stabilisers</strong>, and <strong>safety measures for the infant.</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715405efe0d-ce03-48f0-bec7-4a5e4831b2e4.png\">\n<p><strong>Explanation of other options:<br /> Postpartum Blues (Option A):</strong> Characterised by <strong>mild mood lability, tearfulness, and irritability</strong> in the first <strong>3&ndash;5 days post-delivery</strong>, peaking at 1 week and resolving within 2 weeks. It is self-limiting and not associated with psychotic symptoms.</p>\n<p><strong>Postpartum Depression (Option B): </strong>Presents with <strong>persistent sadness, low energy, poor sleep or appetite, and difficulty bonding with the baby</strong>, but <strong>no psychotic features</strong>. It typically begins <strong>within 4&ndash;6 weeks postpartum</strong> and lasts longer than 2 weeks.</p>\n<p><strong>Mania (Option D)</strong>: Involves <strong>elevated or irritable mood, increased activity, decreased need for sleep, and grandiosity</strong>, but the <strong>delusional content here is specific to the postpartum context</strong>, making <strong>postpartum psychosis</strong> more appropriate. Mania may be a component of postpartum psychosis in bipolar patients.</p>\n<p><strong>Key Takeaway:<br /> Postpartum psychosis</strong> presents with <strong>delusions, hallucinations, and impaired reality testing</strong> within weeks of delivery and requires <strong>immediate intervention</strong>. It is distinct from postpartum blues and depression by its <strong>severity and psychotic features</strong>, making it a <strong>psychiatric emergency</strong>.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Major depression</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjustment disorder</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Personality disorder</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysthymia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old man comes to psychiatry OPD with complaints of irritability, guilt of not being able to perform well in office and decreased interest in recreational activities since he left college 3 years back. What is the most probable diagnosis?</span></p>",
      "unique_key": "DT1221682",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221682,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient describes a <strong>chronic low mood</strong>, <strong>anhedonia</strong>, <strong>irritability</strong>, <strong>low self-esteem</strong>, and <strong>functional impairment that</strong> has persisted for <strong>over 2 years</strong>, all hallmark features of <strong>Dysthymia</strong> (now called <strong>Persistent Depressive Disorder</strong> in DSM-5).</li>\n<li><strong>Major depression (A)</strong> requires more severe symptoms over a shorter duration (&ge;2 weeks) and is <strong>not chronic</strong>. (Option A ruled out)</li>\n<li><strong>Adjustment disorder (B)</strong> involves mood changes triggered by a <strong>specific identifiable stressor</strong>, usually resolving within <strong>6 months</strong> of the stressor. This case lacks a discrete trigger. (Option B ruled out)</li>\n<li><strong>Personality disorder (C)</strong> involves lifelong patterns of behavior, but this presentation centers on <strong>mood disturbance</strong>, not fixed personality traits. (Option C ruled out)<br /> (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Dysthymia = low-grade chronic depression &ge;2 years</strong>.</li>\n<li>Symptoms may be <strong>less severe</strong> but are <strong>long-lasting and disabling</strong>.</li>\n<li>Must differentiate from <strong>major depression</strong> (acute/severe) and <strong>adjustment disorders</strong> (situational/short-term).</li>\n</ul>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Typical depression</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical depression</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatic form disorder</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Involutional melancholia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Agitation, miserable feeling, somatisation, and intense feelings of guilt in a 65-year-old man are the hallmark symptoms of</span></p>",
      "unique_key": "DT1221683",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221683,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Involutional melancholia</strong> is a historical term referring to <strong>severe depression in the elderly</strong>, particularly around the <strong>involutional period (50&ndash;70 years)</strong>.</li>\n<li>Hallmark features include:\n<ul>\n<li><strong>Agitation</strong></li>\n<li><strong>Intense guilt and hopelessness</strong></li>\n<li><strong>Somatic preoccupation (hypochondriasis)</strong></li>\n<li><strong>Psychotic features may be present<br /> </strong>These are seen in this 65-year-old patient, making <strong>Option D</strong> the best fit.</li>\n</ul>\n</li>\n<li><strong>Typical depression (A)</strong> does not characteristically present with <strong>severe agitation and somatic delusions</strong>. (Option A ruled out)</li>\n<li><strong>Atypical depression (B)</strong> typically features <strong>hypersomnia, increased appetite</strong>, and mood reactivity&mdash;not seen here. (Option B ruled out)</li>\n<li><strong>Somatic symptom disorder (C)</strong> focuses on <strong>physical symptoms without major depressive affect</strong>, unlike the clear affective symptoms here. (Option C ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Involutional melancholia = severe, agitated depression in the elderly</strong>, often with <strong>somatic delusions and guilt</strong>.</li>\n<li>Differs from typical and atypical depression by <strong>intensity and age group</strong>.</li>\n<li>May require <strong>antidepressants + antipsychotics or ECT</strong>.</li>\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Paraphilias</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Major depression</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug de addiction</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Histrionic personality disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which psychiatric condition is addressed using the procedure shown in the image?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715e5450282-7b3a-48d2-b2bb-54fa389e54c8.png\"></span></p>",
      "unique_key": "DT1221684",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221684,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The image depicts <strong>Electroconvulsive Therapy (ECT)</strong>, a medical procedure used in psychiatry where controlled electric currents are passed through the brain to induce a <strong>therapeutic seizure</strong>.</li>\n<li><strong>ECT is most commonly used for Major Depressive Disorder (MDD)</strong>, especially in cases that are:\n<ul>\n<li><strong>Treatment-resistant</strong></li>\n<li><strong>Severely suicidal</strong></li>\n<li><strong>Associated with psychotic features</strong></li>\n<li><strong>Catatonic or melancholic</strong> presentations</li>\n</ul>\n</li>\n<li><strong>Paraphilias (A)</strong> are addressed with psychotherapy and hormonal therapy.</li>\n<li><strong>Drug de-addiction (C)</strong> relies on detoxification, medications (e.g., naltrexone, methadone), and behavioural therapy.</li>\n<li><strong>Histrionic personality disorder (D)</strong> is managed with psychotherapy, not ECT.<br /> (Options A, C, and D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>ECT is primarily indicated for severe or treatment-resistant depression</strong>.</li>\n<li>Also used in <strong>mania, schizophrenia (catatonia), and suicidality</strong>.</li>\n<li>Requires <strong>informed consent</strong> and is typically done under <strong>anesthesia and muscle relaxation</strong>.</li>\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Imipramine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Bupropion</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Venlafaxine</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Escitalopram</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">While being treated for depression, a patient presents with complaints of sexual dysfunction and dyspareunia. What is the most suitable alternative medication?</span></p>",
      "unique_key": "DT1221686",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Bupropion</strong> is the most suitable alternative in cases of <strong>SSRI/SNRI-induced sexual dysfunction</strong>, including <strong>dyspareunia</strong>.</li>\n<li>It is a <strong>norepinephrine-dopamine reuptake inhibitor (NDRI)</strong> that has <strong>minimal serotonergic activity</strong>, thus <strong>preserving sexual function</strong>.</li>\n<li><strong>Imipramine</strong> and <strong>Venlafaxine</strong> affect serotonin and are known to cause or worsen sexual side effects.</li>\n<li><strong>Escitalopram</strong> is an SSRI and is commonly associated with <strong>anorgasmia, decreased libido</strong>, and <strong>dyspareunia</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Bupropion is the drug of choice for depression with sexual dysfunction</strong>.</li>\n<li>Avoid <strong>SSRIs, SNRIs, and TCAs</strong> in such patients due to serotonergic sexual side effects.</li>\n<li><strong>Bupropion may also improve energy, motivation</strong>, and is <strong>weight-neutral</strong>.</li>\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">TCA</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI/SNRI</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Bupropion</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Mirtazapine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female, using antidepressants for the last 5 months, is complaining of weight gain. She is asking to change the medicine. Which medicine will be preferred in her case?</span></p>",
      "unique_key": "DT1221687",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Bupropion</strong> is the preferred antidepressant in patients concerned about <strong>weight gain</strong>, as it is associated with <strong>weight neutrality or even weight loss</strong>.</li>\n<li>It acts via <strong>norepinephrine and dopamine reuptake inhibition</strong> and lacks <strong>serotonergic activity</strong>, which contributes to a <strong>lower risk of appetite stimulation or metabolic weight gain</strong>.</li>\n<li><strong>Tricyclic antidepressants (TCAs)</strong> and <strong>mirtazapine</strong> are well-known for causing <strong>significant weight gain</strong>.</li>\n<li>Many <strong>SSRIs and SNRIs</strong> (especially paroxetine and mirtazapine) are also linked with <strong>weight gain over prolonged use</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Bupropion is weight-neutral or can cause weight loss</strong>&mdash;ideal for weight-conscious patients.</li>\n<li><strong>TCAs, SSRIs/SNRIs, and mirtazapine</strong> can cause <strong>weight gain</strong> and should be avoided in such cases.</li>\n<li>Also beneficial in patients with <strong>low energy, fatigue, or nicotine dependence</strong>.</li>\n</ul>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">TCA</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Mirtazapine</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Trazadone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antidepressants is least likely to be associated with sedation?</span></p>",
      "unique_key": "DT1221688",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Selective Serotonin Reuptake Inhibitors (SSRIs)</strong> are generally the <strong>least sedating</strong> class of antidepressants, making them suitable for daytime administration and patients sensitive to drowsiness.</li>\n<li><strong>Tricyclic antidepressants (TCAs)</strong> and <strong>mirtazapine</strong> are <strong>highly sedating</strong> due to their <strong>antihistaminergic activity</strong>.</li>\n<li><strong>Trazodone</strong>, though often prescribed at low doses for <strong>insomnia</strong>, is also <strong>notable for sedation</strong> due to potent <strong>H1 receptor blockade</strong> and <strong>alpha-1 antagonism</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>SSRIs are least associated with sedation</strong>, hence preferred when alertness is a priority.</li>\n<li><strong>TCA, mirtazapine, and trazodone</strong> can cause significant sedation.</li>\n<li>Consider the <strong>side effect profile when tailoring antidepressant therapy</strong>.</li>\n</ul>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">TCA</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">SNRI</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">MAO inhibitors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young female on antidepressants presents to the emergency department with altered sensorium, hyperthermia, mydriasis, blurred vision and hypotension. ECG reveals wide QRS complexes and right axis deviation. This can be due to the toxicity of</span></p>",
      "unique_key": "DT1221689",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient presents with signs of <strong>anticholinergic toxicity (mydriasis, blurred vision, altered sensorium)</strong>, <strong>cardiotoxicity (hypotension, wide QRS, right axis deviation)</strong>, and <strong>hyperthermia</strong>, all of which are classic features of <strong>tricyclic antidepressant (TCA) overdose</strong>.</li>\n<li>TCAs block <strong>muscarinic receptors</strong>, <strong>sodium channels</strong> (causing QRS widening and arrhythmias), and <strong>alpha-adrenergic receptors</strong> (causing hypotension).</li>\n<li><strong>SSRIs and SNRIs</strong> are less cardiotoxic and would typically cause <strong>serotonin syndrome</strong>, not QRS prolongation (Option A &amp; C ruled out).</li>\n<li><strong>MAO inhibitors</strong> can cause hypertensive crises and serotonin toxicity, but not the <strong>distinct ECG findings</strong> seen here (Option D ruled out).</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>TCA toxicity presents with anticholinergic and cardiac features</strong> (e.g., wide QRS, hypotension).</li>\n<li>ECG changes in TCA overdose include <strong>QRS widening and right axis deviation</strong>.</li>\n<li>Management includes <strong>sodium bicarbonate</strong>, airway protection, and cardiac monitoring.</li>\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Antipsychotics + Mood stabilizers</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Antidepressants + Benzodiazepines</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Antipsychotics + Antidepressants</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Antidepressants + Mood stabilizers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44 year old male with a past history of a manic episode presents with an illness of 1 month duration characterized by depressed mood, anhedonia and profound psychomotor retardation. The most appropriate management strategy is prescribing a combination of:</span></p>",
      "unique_key": "DT1221690",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221690,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient has a known history of <strong>bipolar disorder (previous manic episode)</strong> and is currently presenting with <strong>a depressive episode</strong> (depressed mood, anhedonia, psychomotor retardation).</li>\n<li>In <strong>bipolar depression</strong>, <strong>antidepressants should never be used alone</strong>, as they can precipitate <strong>manic switches</strong>.</li>\n<li>The most appropriate strategy is a <strong>combination of an antidepressant with a mood stabilizer</strong> (like lithium, valproate, or lamotrigine) to manage depressive symptoms while <strong>preventing manic relapse</strong>.</li>\n<li><strong>Benzodiazepines</strong> do not treat core depressive symptoms.</li>\n<li><strong>Antipsychotics</strong> are not first-line for bipolar depression unless psychotic features or mania are present.</li>\n<li><strong>Antipsychotic + antidepressant</strong> is not standard for bipolar depression management.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Bipolar depression is managed with antidepressants + mood stabilizers</strong>.</li>\n<li><strong>Monotherapy with antidepressants is avoided</strong> due to risk of mood destabilization.</li>\n<li>Mood stabilizers ensure <strong>long-term mood control and relapse prevention</strong>.</li>\n</ul>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Cocaine abuse</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Earlier suicidal attempt</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Low level of 5-HIAA</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Adolescent age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following factors is least likely to be a reliable predictor of suicide risk?</span></p>",
      "unique_key": "DT1221691",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221691,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>While <strong>adolescents do attempt suicide</strong>, <strong>age alone</strong> is not a <strong>strong independent predictor</strong> of suicide <strong>risk</strong>. It must be considered alongside other factors like mental illness, substance use, and family history.</li>\n<li><strong>Previous suicide attempts</strong> are one of the <strong>strongest predictors</strong> of future suicide.</li>\n<li><strong>Cocaine abuse</strong> significantly increases suicide risk due to its link with impulsivity and depression.</li>\n<li><strong>Low levels of 5-HIAA (5-hydroxyindoleacetic acid)</strong>, a serotonin metabolite, are associated with <strong>increased impulsivity and suicidal behavior</strong>, particularly in major depression.<br /> (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Adolescent age alone is not a reliable predictor</strong>&mdash;contextual risk factors matter more.</li>\n<li><strong>Past suicide attempts and substance abuse</strong> are among the strongest predictors.</li>\n<li><strong>Low 5-HIAA</strong> indicates <strong>serotonergic dysregulation</strong> and is biologically linked to suicide risk.</li>\n</ul>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol dependence</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Impulsive control disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old man has presented with increased alcohol consumption & sexual indulgence, irritability, lack of sleep & not feeling fatigued even on prolonged periods of activity. All these changes have been seen for the last 3 weeks. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1221692",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221692,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient displays <strong>classic manic symptoms</strong> including:\n<ul>\n<li><strong>Increased goal-directed activity</strong> (sexual indulgence, alcohol use)</li>\n<li><strong>Decreased need for sleep</strong> without fatigue</li>\n<li><strong>Irritability</strong></li>\n<li><strong>Elevated energy levels</strong> lasting for <strong>&ge;1 week</strong>, here persisting for <strong>3 weeks</strong></li>\n</ul>\n</li>\n<li>These features are diagnostic of a <strong>manic episode</strong>, especially in the context of <strong>mood elevation, hyperactivity, and impaired judgment</strong>.</li>\n<li><strong>Alcohol dependence (A)</strong> may involve heavy use but does <strong>not explain elevated mood and reduced need for sleep</strong>.</li>\n<li><strong>Schizophrenia (C)</strong> features <strong>delusions, hallucinations</strong>, and <strong>thought disorder</strong>, not primarily mood symptoms.</li>\n<li><strong>Impulse control disorder (D)</strong> involves isolated impulsive acts, not a <strong>sustained elevated mood state</strong> with reduced sleep and hyperactivity.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Mania = elevated mood, hyperactivity, decreased sleep, disinhibition, and irritability &ge;1 week</strong>.</li>\n<li>Requires careful differentiation from <strong>substance use</strong> and <strong>psychotic disorders</strong>.</li>\n<li><strong>Mood stabilizers and antipsychotics</strong> are mainstays of treatment.</li>\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Depersonalization</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Grandiose delusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Nihilistic delusions will be congruent with which of the following findings of mental state examination?</span></p>",
      "unique_key": "DT1221695",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221695,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Nihilistic delusions</strong> are false beliefs of <strong>nonexistence, extreme pessimism</strong>, or <strong>bodily decay</strong>, often seen in <strong>severe or psychotic depression</strong>. These delusions are <strong>mood-congruent with depressive states</strong>, especially in <strong>involutional melancholia</strong> or <strong>major depressive disorder with psychotic features</strong>.</li>\n<li><strong>Mania</strong> is associated with <strong>grandiose, elated, or persecutory delusions</strong>, not nihilistic ones. (Option B ruled out)</li>\n<li><strong>Depersonalization</strong> involves <strong>subjective detachment or unreality</strong>, not fixed false beliefs or delusions. (Option C ruled out)</li>\n<li><strong>Grandiose delusions</strong> are characteristic of <strong>mania</strong>, reflecting inflated self-worth or power, not hopelessness or nonexistence. (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Nihilistic delusions align with depressive psychosis</strong>.</li>\n<li><strong>Delusional content is often mood-congruent</strong> in affective disorders.</li>\n<li>Distinguishing <strong>depression from mania or dissociation</strong> is critical in diagnosis.</li>\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticosteroids</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Antipsychotics</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-obesity drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman presented with features like depressed mood, lack of interest in pleasurable activities, decreased sleep and easy fatigability. Along with this, she also noticed some physical symptoms like dry skin, hair loss, hoarse voice, weight gain and increased sensitivity to cold. Such symptoms would improve with the administration of:</span></p>",
      "unique_key": "DT1221696",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221696,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The woman presents with symptoms of <strong>depression</strong> along with <strong>classic signs of hypothyroidism,</strong> such as <strong>dry skin, hair loss, hoarseness, weight gain</strong>, and <strong>cold intolerance</strong>.</li>\n<li><strong>Hypothyroidism is a well-known reversible cause of secondary depression</strong>, and treating the underlying <strong>thyroid hormone deficiency with thyroxine (levothyroxine)</strong> typically improves both <strong>mood and physical symptoms</strong>.</li>\n<li><strong>Corticosteroids</strong> are not indicated and may worsen mood or metabolic symptoms. (Option B ruled out)</li>\n<li><strong>Antipsychotics</strong> are not useful unless psychosis is present; they may worsen hypothyroid symptoms. (Option C ruled out)</li>\n<li><strong>Anti-obesity drugs</strong> do not address the underlying endocrine disturbance. (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Hypothyroidism can mimic depressive disorder</strong>, and treating with <strong>thyroxine</strong> corrects both psychiatric and physical symptoms.</li>\n<li>Always rule out <strong>organic causes of depression</strong> before starting antidepressants.</li>\n<li><strong>Thyroid function tests are essential in evaluating mood disorders</strong>.</li>\n</ul>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Baby blues</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjustment disorder</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalised Anxiety Disorder (GAD)</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Major depressive episode with postpartum onset</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman is referred for assessment by the obstetric team. She is reported to be feeling depressed following the birth of her first baby three days ago. She has no history of depressive disorder. The baby is healthy, although the woman required a caesarean delivery. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1221699",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221699,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Postpartum blues</strong> (or <strong>\"baby blues\"</strong>) typically occur in <strong>50-80% of women</strong> within the <strong>first 3-6 days</strong> after delivery. It is characterized by <strong>emotional lability, tearfulness, anxiety, and mild depressive symptoms</strong>, usually peaking around day 5 and resolving spontaneously within <strong>2 weeks</strong>. There is <strong>no functional impairment</strong>, and the mother can still care for the baby.</p>\n<ul>\n<li>Onset: <strong>3-6 days postpartum</strong></li>\n<li>Symptoms: <strong>Mood swings, crying spells, anxiety, irritability, poor sleep</strong></li>\n<li>Self-limiting; resolves within <strong>2 weeks</strong></li>\n<li>Does <strong>not require pharmacological treatment</strong>, only reassurance and support</li>\n</ul>\n<p><strong>Explanation for Other options:</strong></p>\n<p><strong>Adjustment disorder (Option B):</strong> Occurs within <strong>3 months of a stressor</strong> and includes <strong>emotional or behavioural symptoms,</strong> but typically persists longer and is not specific to the postpartum timeline.</p>\n<p><strong>GAD</strong> <strong>(Option c)</strong> requires excessive worry lasting at least 6 months. The emotional changes here are typical of baby blues, not a chronic anxiety disorder.</p>\n<p><strong>Major depressive episode with postpartum onset</strong> <strong>(Option D):</strong> Presents with <strong>severe depressive symptoms</strong>, including <strong>anhedonia, feelings of worthlessness, guilt, and possibly suicidal ideation</strong>, typically occurring within <strong>4-6 weeks postpartum</strong>, not just 3 days post-delivery.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Postpartum blues</strong> are <strong>transient, mild depressive symptoms</strong> commonly seen in the <strong>first week after childbirth</strong> and resolve spontaneously. Unlike <strong>postpartum depression</strong>, they <strong>do not impair functioning</strong> or require medication. Always assess <strong>time of onset, severity, and functional impact</strong> to differentiate postpartum mood disorders.</p>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5-1%</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">5-10%</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">15%</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">20%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following most closely reflects the risk of bipolar affective disorder in a first degree relative of an affected proband?</span></p>",
      "unique_key": "DT1221700",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221700,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The lifetime risk of <strong>bipolar affective disorder (BPAD)</strong> in the <strong>general population</strong> is about <strong>1%</strong>, but the risk <strong>increases significantly in first-degree relatives</strong> (parents, siblings, children) of an affected individual-approximately <strong>5-10%</strong>.</li>\n<li>This supports a <strong>strong genetic contribution</strong> to BPAD, though <strong>environmental and neurobiological factors</strong> also play roles.</li>\n<li>If <strong>both parents are affected</strong>, the risk can rise to <strong>~50&ndash;60%</strong>, suggesting <strong>polygenic inheritance with variable penetrance</strong>.</li>\n<li><strong>Option A (0.5&ndash;1%)</strong> reflects the general population risk. (Option A ruled out)</li>\n<li><strong>Option C (15%)</strong> and <strong>Option D (20%)</strong> are overestimates for a single first-degree relative. (Options C and D ruled out)</li>\n</ul>\n<p><strong>Aetiology of Bipolar Disorder:</strong></p>\n<ul>\n<li><strong>Genetic</strong>: Strong familial aggregation; several <strong>candidate genes</strong> (e.g., CACNA1C, ANK3) identified.</li>\n<li><strong>Neurochemical</strong>: Dysregulation of <strong>dopamine, serotonin, and norepinephrine</strong>.</li>\n<li><strong>Neuroendocrine</strong>: HPA axis dysfunction.</li>\n<li><strong>Psychosocial</strong>: Stressful life events may precipitate episodes in vulnerable individuals.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Risk in first-degree relatives = 5&ndash;10%</strong>; higher with both parents affected.</li>\n<li><strong>BPAD has a multifactorial etiology</strong>&mdash;genetic, neurochemical, and environmental.</li>\n<li>Early recognition and family screening are important in <strong>high-risk individuals</strong>.</li>\n</ul>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Acromegaly</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's disease</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following disorders is least likely to be an underlying cause of depressive disorder?</span></p>",
      "unique_key": "DT1221702",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221702,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Depression is commonly associated with several endocrine disorders</strong>, but <strong>acromegaly</strong> is <strong>least likely</strong> to be a direct cause. Though mood changes can occur, depression is not a prominent feature.</li>\n<li><strong>Addison&rsquo;s disease</strong> (chronic adrenal insufficiency) often presents with <strong>fatigue, apathy, and depressive symptoms due</strong> to low cortisol levels.</li>\n<li><strong>Cushing&rsquo;s disease</strong> (excess cortisol from a pituitary adenoma) is strongly linked to <strong>mood disorders, especially depression</strong>, due to cortisol&rsquo;s neurotoxic effects.</li>\n<li><strong>Hypothyroidism</strong> is a <strong>well-known cause of secondary depression</strong>, with features like <strong>fatigue, low mood, cognitive slowing</strong>, and <strong>psychomotor retardation</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Hypothyroidism, Addison&rsquo;s, and Cushing&rsquo;s disease are common endocrine causes of depression</strong>.</li>\n<li><strong>Acromegaly</strong>, though it may cause personality change or fatigue, is <strong>not a typical cause of major depressive disorder</strong>.</li>\n<li>Always screen for <strong>underlying endocrine conditions</strong> in treatment-resistant or atypical depression.</li>\n</ul>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Approximately two-thirds of patients with depressive disorder are treated successfully with antidepressant medication alone</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined treatment with antidepressant medication and cognitive behavioural therapy (CBT) confers an additional treatment effect of approximately 30% over treatment with each treatment alone</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Relapse rates following treatment discontinuation are higher in those taking medication compared with those who have received CBT</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">CBT is just as effective in the treatment of severe depressive disorder as antidepressant medication</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding the treatment of unipolar depressive disorder in adults, which one of the following statements is least true?</span></p>",
      "unique_key": "DT1221703",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221703,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Relapse rates</strong> are generally <strong>lower in patients treated with CBT</strong> compared to those who rely solely on medication. This is because <strong>CBT equips patients with long-term coping strategies</strong> and cognitive restructuring tools, while <strong>antidepressants manage symptoms but don&rsquo;t change underlying thought patterns</strong>.</li>\n<li><strong>Option A</strong> is true: about <strong>two-thirds</strong> of patients with depression show significant improvement with antidepressants alone.</li>\n<li><strong>Option B</strong> is true: combining <strong>CBT and medication</strong> offers a <strong>synergistic benefit</strong>, with around <strong>30% greater improvement</strong> than either modality alone.</li>\n<li><strong>Option D</strong> is true: evidence supports that <strong>CBT is equally effective</strong> as antidepressants in <strong>moderate to severe depression</strong>, especially when adherence is good and skilled therapy is available.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>CBT has lower relapse rates</strong> compared to medication after discontinuation.</li>\n<li><strong>Combination therapy</strong> is superior to monotherapy in unipolar depression.</li>\n<li><strong>CBT is effective across all severities of depression</strong>, particularly when maintained long-term.</li>\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysthymia typically starts in middle age</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Individuals with more than one medical condition are twice as likely to suffer a severe depressive episode.</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Unipolar mania is equally common among males and females.</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Women with bipolar affective disorder are more likely to suffer a depressive episode than men</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding the epidemiology of affective disorders, which of the following is most correct?</span></p>",
      "unique_key": "DT1221704",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221704,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Women with bipolar disorder</strong> tend to experience <strong>more depressive episodes</strong> and <strong>mixed features</strong>, while <strong>men</strong> are more likely to present with <strong>manic episodes</strong>. This sex-based pattern is a consistent epidemiological finding in affective disorders.</li>\n<li><strong>Dysthymia (Persistent Depressive Disorder)</strong> usually has an <strong>early onset in adolescence or young adulthood</strong>, not middle age. (Option A ruled out)</li>\n<li>Although <strong>comorbid medical conditions</strong> increase depression risk, the statement that they're <strong>\"twice as likely\"</strong> is vague and lacks specificity. (Option B ruled out)</li>\n<li><strong>Unipolar mania</strong> is rare and occurs more frequently in <strong>males</strong>, not equally among both sexes. (Option C ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Women with bipolar disorder experience more depressive episodes</strong>.</li>\n<li><strong>Dysthymia typically begins in youth</strong>, not midlife.</li>\n<li><strong>Unipolar mania is uncommon and more prevalent in males</strong>.</li>\n</ul>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">The lifetime risk of bipolar disorder lies between 0.3% and 1.5%</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">The prevalence in men and women is almost same</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Female sufferers have proportionately fewer manic episodes</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">The age of onset is later in bipolar disorder than in major depressive disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In relation to the epidemiology of bipolar affective disorder, which one of the following is least correct?</span></p>",
      "unique_key": "DT1221705",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221705,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Bipolar disorder</strong> typically begins in <strong>late adolescence or early adulthood (18&ndash;25 years)</strong>, while <strong>major depressive disorder</strong> often starts slightly later. Therefore, the statement that bipolar onset is later is incorrect.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>The lifetime risk of bipolar disorder lies between 0.3% and 1.5% (Option A):</strong> Correct as per DSM-5 epidemiological estimates.</p>\n<p><strong>The prevalence in men and women is almost the same (Option B):</strong> Accurate. Although symptom profiles differ (e.g., women with more depression, men with more mania), overall prevalence is similar.</p>\n<p><strong>Female sufferers have proportionately fewer manic episodes (Option C):</strong> Correct. Women tend to experience more <strong>depressive</strong> and <strong>mixed episodes</strong>, while men show more <strong>manic episodes</strong>.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Bipolar disorder has earlier onset than unipolar depression</strong></li>\n<li><strong>Equal gender prevalence, differing symptom patterns</strong></li>\n<li>Epidemiological knowledge supports <strong>early detection and subtype identification</strong></li>\n</ul>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed affective state</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizophreniform psychosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common psychiatric disturbance associated with Cushing's disease is</span></p>",
      "unique_key": "DT1221706",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221706,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Depression</strong> is the most common psychiatric manifestation in <strong>Cushing&rsquo;s disease</strong> due to <strong>elevated cortisol</strong>, which disrupts mood regulation by impairing <strong>serotonin and hippocampal function</strong>. Patients often present with <strong>low mood, anhedonia, fatigue, and cognitive slowing</strong>, which may mimic primary depressive disorders.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<ul>\n<li><strong>Mania (Option B):</strong> Not typically seen in hypercortisolism; cortisol excess more commonly causes <strong>depressive symptoms</strong>.</li>\n<li><strong>Mixed affective state (Option C):</strong> Rare in endocrine disorders; mood changes do not usually meet full criteria for both mania and depression.</li>\n<li><strong>Schizophreniform psychosis (Option D):</strong> Psychotic symptoms may occur in extreme cases but do not resemble <strong>schizophreniform disorder</strong>, which includes disorganised speech and delusions.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Depression is the most frequent psychiatric effect of Cushing&rsquo;s disease</strong>.</li>\n<li><strong>Cortisol excess disturbs neurochemistry</strong>, especially serotonin balance.</li>\n<li><strong>Psychotic or manic features are uncommon</strong> and secondary if present.</li>\n</ul>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Interepisode recovery</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of delusions</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Religious content of hallucinations</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Family history</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most important diagnostic information that differentiates bipolar disorder from schizophrenia?</span></p>",
      "unique_key": "DT1221708",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221708,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Interepisode recovery</strong>, or the <strong>return to baseline functioning between episodes</strong>, is a defining characteristic of <strong>bipolar disorder</strong>. Patients with bipolar disorder often experience <strong>complete remission</strong> between manic or depressive episodes.</li>\n<li>In contrast, <strong>schizophrenia</strong> typically involves <strong>persistent residual symptoms</strong>, <strong>cognitive impairment</strong>, and <strong>functional decline</strong>, even during periods of symptom remission.</li>\n<li><strong>The presence of delusions</strong> is common in both schizophrenia and bipolar disorder with psychotic features and does not help differentiate them. (Option B ruled out)</li>\n<li><strong>Religious content of hallucinations</strong> can occur in both disorders and is not unique to either. (Option C ruled out)</li>\n<li><strong>Family history</strong> may be present in both conditions and is not specific for diagnosis. (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Full recovery between episodes favours bipolar disorder</strong>, not schizophrenia.</li>\n<li>Schizophrenia often involves <strong>chronic impairment</strong> even when not acutely psychotic.</li>\n<li><strong>Psychotic features and family history</strong> are shared and not diagnostic.</li>\n</ul>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Family history</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Life events</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Past history of depression</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Low IQ</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Strong risk factors for depression include all of the following EXCEPT</span></p>",
      "unique_key": "DT1221709",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221709,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Low IQ</strong> is <strong>not a well-established or direct risk factor</strong> for developing depression. While it may influence coping mechanisms or socioeconomic status, it does <strong>not have a strong independent predictive value</strong> for depressive disorders.</li>\n<li><strong>Family history of depression</strong> is one of the <strong>strongest risk factors</strong>, reflecting genetic vulnerability. (Option A ruled out)</li>\n<li><strong>Stressful life events</strong> (e.g., bereavement, trauma) are potent <strong>precipitating factors</strong> for depression. (Option B ruled out)</li>\n<li>A <strong>past history of depression</strong> is a major predictor of recurrence, indicating <strong>underlying biological and psychological vulnerability</strong>. (Option C ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Low IQ is not a direct risk factor for depression</strong>.</li>\n<li>Major risk factors include <strong>genetics, life events, and prior depressive episodes</strong>.</li>\n<li>Clinical evaluation should focus on <strong>psychosocial history and family background</strong>.</li>\n</ul>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Leaden paralysis</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Reversed vegetative signs</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Rejection sensitivity</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight loss</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT a characteristic feature of atypical depression?</span></p>",
      "unique_key": "DT1221710",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221710,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Atypical depression</strong> includes the features of <strong>mood reactivity</strong>, <strong>leaden paralysis</strong>, <strong>reversed vegetative signs</strong> (e.g., <strong>increased sleep and appetite</strong>), and <strong>rejection sensitivity</strong>.</li>\n<li><strong>Weight loss</strong> is a hallmark of <strong>typical (melancholic) depression</strong>, which typically features <strong>anhedonia</strong>, <strong>early morning awakening</strong>, <strong>psychomotor retardation or agitation</strong>, <strong>decreased appetite</strong>, and <strong>diurnal mood variation (worse in morning)</strong>.<br /> (Option D ruled out)</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250715efc4977d-133b-4bfd-8d2c-7834bced8a47.png\">\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Atypical depression presents with reversed vegetative symptoms and mood reactivity</strong></li>\n<li><strong>Weight loss</strong> is more typical of <strong>melancholic depression</strong>, not atypical</li>\n<li>Subtyping helps guide <strong>treatment choice</strong>, e.g., <strong>MAOIs</strong> in atypical cases</li>\n</ul>",
      "correct_choice_id": 254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleeding disorder</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyponatraemia</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary retention</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 80-year-old woman with a history of chronic obstructive pulmonary disease and right heart failure, the latter treated with diuretics, presents with depressive disorder. There is no history of stroke. You intend to prescribe a selective serotonin reuptake inhibitor. Which adverse event would you be most concerned about monitoring?</span></p>",
      "unique_key": "DT1221711",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hyponatraemia</strong> is the most significant concern when prescribing <strong>Selective Serotonin Reuptake Inhibitors (SSRIs)</strong>, especially in <strong>elderly patients</strong>, and particularly in those on <strong>diuretics</strong> As in this case with right heart failure). SSRIs can induce <strong>Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)</strong>, leading to dilutional hyponatraemia.</li>\n<li>The risk is magnified in older adults due to increased sensitivity and renal susceptibility, and <strong>concomitant use of diuretics</strong> further exacerbates sodium loss, compounding the risk.</li>\n<li>The clinical manifestation may range from mild symptoms (fatigue, confusion) to severe effects (seizures, coma). Therefore, <strong>serum sodium levels should be monitored</strong> when initiating or adjusting SSRI therapy in such high-risk populations.</li>\n<li>SSRIs commonly associated with SIADH: fluoxetine, sertraline, citalopram.</li>\n<li>Elderly patients, particularly females, are more vulnerable.</li>\n<li>Regular <strong>electrolyte monitoring</strong> is crucial during antidepressant therapy initiation in at-risk groups.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Bleeding disorder (Option A) </strong>SSRIs can increase bleeding risk due to platelet serotonin depletion, but <strong>this is not the most immediate or likely concern</strong> in this patient with no history of GI bleeding, anticoagulant use, or other bleeding disorders.</p>\n<p><strong>Diabetes mellitus (Option B) </strong>Not directly associated with SSRIs. Some atypical antidepressants (e.g., mirtazapine, TCAs) may impact glycemic control more significantly.</p>\n<p><strong>Urinary retention (Option D) </strong>More commonly a side effect of <strong>TCAs</strong> and <strong>anticholinergic drugs</strong>, not SSRIs. SSRIs generally do not affect bladder function significantly.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Hyponatraemia is a serious and common SSRI-related adverse effect in the elderly, especially with diuretic use.</li>\n<li>SSRIs are otherwise well-tolerated but should be used with caution in medically fragile populations.</li>\n<li>Electrolyte monitoring is crucial in elderly psychiatric pharmacotherapy.</li>\n</ul>",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Disruptive mood dysregulation disorder</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Premenstrual dysphoric disorder</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute stress disorder</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysthymia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following conditions are included in 'depressive disorders' section of DSM-5 except:</span></p>",
      "unique_key": "DT1221712",
      "question_audio": null,
      "question_video": null,
      "map_id": 1221712,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Acute stress disorder</strong> is classified under <strong>\"Trauma- and Stressor-Related Disorders\"</strong> in DSM-5, not under <strong>\"Depressive Disorders\"</strong>. It is characterized by <strong>acute anxiety, dissociation, and other symptoms</strong> following a traumatic event, typically lasting <strong>3 days to 1 month</strong>.</li>\n<li><strong>Disruptive mood dysregulation disorder (DMDD)</strong> was introduced in DSM-5 to address <strong>chronic irritability and temper outbursts in children</strong>, and is listed under <strong>depressive disorders</strong>. (Option A ruled out)</li>\n<li><strong>Premenstrual dysphoric disorder (PMDD)</strong> is also included under <strong>depressive disorders</strong>, given its mood-related cyclical nature. (Option B ruled out)</li>\n<li><strong>Dysthymia</strong>, now termed <strong>Persistent Depressive Disorder</strong>, is a chronic form of depression included in the depressive disorders section. (Option D ruled out)</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Acute stress disorder is a trauma-related condition</strong>, not a depressive disorder.</li>\n<li>DSM-5 includes <strong>DMDD, PMDD, and dysthymia</strong> under <strong>depressive disorders</strong>.</li>\n<li>Proper classification helps tailor <strong>diagnostic criteria and treatment approaches</strong>.</li>\n</ul>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypomania</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclothymia</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysthymia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old woman has felt unusually energetic, overly confident, talkative, and required only 3 hours of sleep per night for the past 5 days. Her colleagues notice increased productivity and sociability, but no signs of psychosis or major functional impairment. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1324087",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324087,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\r\n<ul>\r\n<li>The patient's symptoms of <strong>elevated mood, reduced need for sleep, increased productivity</strong>, and <strong>talkativeness</strong>lasting <strong>5 days</strong> with <strong>no marked impairment or psychosis</strong> meet criteria for <strong>hypomania</strong>.</li>\r\n<li><strong>Hypomania</strong> is defined as <strong>at least 4 consecutive days</strong> of elevated or irritable mood and increased activity or energy, observable by others, without causing significant impairment or hospitalization.</li>\r\n<li><strong>Mania</strong> requires <strong>&ge;7 days</strong>, or any duration if hospitalization or psychosis is present. (Option A ruled out)</li>\r\n<li><strong>Cyclothymia</strong> is a chronic fluctuating mood disorder present for <strong>&ge;2 years</strong>, not a single episode. (Option C ruled out)</li>\r\n<li><strong>Dysthymia (Persistent Depressive Disorder)</strong> is a <strong>chronic depressive mood lasting &ge;2 years</strong>, not elevated mood. (Option D ruled out)</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Mania</strong>: &ge;7 days or any duration with hospitalization/psychosis</li>\r\n<li><strong>Hypomania</strong>: &ge;4 days, no severe impairment or psychosis</li>\r\n<li><strong>Dysthymia</strong>: &ge;2 years of persistent depressive symptoms</li>\r\n<li><strong>Cyclothymia</strong>: &ge;2 years of hypomanic and depressive symptoms not meeting full criteria for bipolar disorder</li>\r\n</ul>",
      "correct_choice_id": 282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}